Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Solid who wrote (4351)	7/15/1998 12:26:00 PM
From: Anthony Wong	Read Replies (1) \| Respond to of 9523

Japan Says Man Died After Taking Pfizer's Viagra (Update1) Bloomberg News July 15, 1998, 7:08 a.m. ET Japan Says Man Died After Taking Pfizer's Viagra (Update1) (Adds Pfizer profit in penultimate paragraph. ) Tokyo, July 15 (Bloomberg) -- A Japanese man in his 60s died earlier this month after taking Viagra, the anti-impotence drug sold by Pfizer Inc., the Japanese Ministry of Heath and Welfare said. The man, who was taking nitroglycerin for high-blood pressure and diabetes, took one tablet of Viagra, which he obtained from a friend. The man had sexual intercourse and died three and a half hours after taking the drug, the ministry said. The Japanese ministry said it hasn't determined if there's a link between the man's death and the drug. Pfizer says Viagra is safe if taken as instructed. Men taking nitrate heart drugs, though, shouldn't take Viagra because of possible adverse reactions. In Japan, the sale of Viagra isn't authorized. Consumers are allowed to import the drug for individual use. Another ministry official said men purchase the drug through Internet. The ministry doesn't know how many Viagra pills are brought into Japan, the official said. New York-based Pfizer said last week its second-quarter profit rose 38 percent, to $628 million, as the second-largest U.S. drugmaker introduced Viagra to unprecedented demand. Pfizer fell 3/16 to 51 ª in the U.S. --Junko Fujita in the Tokyo newsroom (813) 3201-8211/re /rdm